Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Last NR is two weeks old.

<< Previous

Bullboard Posts

Next >>

Comment by CAinPlapon Sep 18, 2024 3:25pm

289 Views

Post# 36229635

RE:RE:RE:RE:RE:Last NR is two weeks old.

Unless we get a significant share price increase on either the BTD submission or another catalyst like herpes vaccine, I hope our funding comes in the form of government grants or debt. $10 million would get 20 - 25% of the company at current prices. Yes I do know how hard/risky it is to get loans without revenue but hopefully our revenue will soon follow.

<< Previous

Bullboard Posts

Next >>

Golden Minerals closes Yoquivo gold-silver project sale